SAN DIEGO, Aug. 10, 2011 /PRNewswire/ -- MicroConstants, Inc., a bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) in San Diego, announces the appointment of Lilin Wang as the new manager of their Immunology Department. Lilin brings to MicroConstants more than 18 years of experience developing immunological and molecular assays to support preclinical and clinical drug development studies. His expertise will enable the company to provide additional contract research services to pharmaceutical and biotech companies developing large molecule drugs and other biologics.
"Our Immunology Department was established in 2007 to provide immunoassay and biomarker analysis services to clients developing proteins and peptides," says David Beyerlein, vice president of global operations at MicroConstants, Inc. "Lilin's experience will allow us to expand those services to also include cell-based and molecular assay development which can provide insight into drug metabolism and drug target interactions in vivo."
In addition to leading the expansion of MicroConstants' Immunology Department, Lilin will serve as a principal investigator and direct the development and validation of ELISA immunoassays, enzymatic activity assays, and immunogenicity testing for pharmaceuticals, biomarkers, and antibodies.
Prior to joining MicroConstants, Lilin spent several years consulting for pharmaceutical and biotech companies. During that time, he developed immunological and molecular assays for cancer and autoimmune diseases, performed antibody generation and validation, and developed novel nanoparticle-based immunofluorescence assays. Lilin has also held scientific and leadership positions at other CROs and pharmaceutical companies conducting research and development in the areas of immunotherapies and biomarkers.
Lilin earned his bachelor's degree in Molecular Cell Biology/Immunology and his master's degree in Immunology from Wuhan University in China. He is an inventor of several patents and the author of peer reviewed scientific publications on topics such as immunology, cancer biology, and infectious diseases.
About MicroConstants, Inc.
MicroConstants is a specialty Contract Research Organization (CRO) in San Diego, California that provides GLP-compliant bioanalytical research services, ELISA immunoassay, drug metabolism (DMPK) assays, and pharmacokinetic analysis services to pharmaceutical and biotech companies developing new chemical entities worldwide. They specialize in method development, method validation, and sample analysis of small molecules, proteins, and peptides using LC/MS/MS, HPLC/UV, and ELISA for preclinical and clinical drug development studies. For more information about MicroConstants and the contract research services they provide, please visit http://www.microconstants.com.
SOURCE MicroConstants, Inc.
